Back to search
Endometrial Endometrioid Adenocarcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Endometrial Endometrioid Adenocarcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Endometrial Endometrioid Adenocarcinoma trials you may qualify forThis phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesg…
This phase Ib trial tests the safety, side effects, and best dose of M1774 when given with ZEN-3694 in treating patients with ovarian and endometrial cancer tha…
This phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismatc…
This study seeks to better understand the recurrence of high-risk endometrial cancer. It will collect information about cancer genetics to find out various here…
This study will explore the use of glucagon-like peptide 1 receptor agonist (GLP-1RA) used concurrently with levonorgestrel intrauterine device in patients with…
This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a l…
This clinical trial studies positron emission tomography (PET)/computed tomography (CT) and lymph node mapping in finding lymph node metastasis in patients with…
This phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone…